On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma

SIMPLE SUMMARY: Regorafenib after sorafenib therapy improved survival in patients with advanced hepatocellular carcinoma in the RESORCE study. The aim of our retrospective study was to investigate the predictors of response and outcome of regorafenib therapy in patients with unresectable hepatocellu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hung-Wei, Chuang, Po-Heng, Su, Wen-Pang, Kao, Jung-Ta, Hsu, Wei-Fan, Lin, Chun-Che, Huang, Guan-Tarn, Lin, Jaw-Town, Lai, Hsueh-Chou, Peng, Cheng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345148/
https://www.ncbi.nlm.nih.gov/pubmed/34359658
http://dx.doi.org/10.3390/cancers13153758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345148/
https://www.ncbi.nlm.nih.gov/pubmed/34359658
http://dx.doi.org/10.3390/cancers13153758

Ejemplares similares